Eledon Pharmaceuticals (ELDN) Institutional Ownership $4.36 +0.14 (+3.32%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Eledon Pharmaceuticals (NASDAQ:ELDN)CurrentInstitutional OwnershipPercentage56.77%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$3.29MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.68M Get ELDN Insider Trade Alerts Want to know when executives and insiders are buying or selling Eledon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELDN Institutional Buying and Selling by Quarter Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Eledon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC378,058$942K0.0%+9.7%0.953% 11/15/2024 Zimmer Partners LP1,434,727$3.57M0.1%-32.0%3.618% 10/30/2024 Clarity Capital Partners LLC11,500$29K0.0%N/A0.029% 8/20/2024 Nantahala Capital Management LLC600,000$1.58M0.1%N/A2.418% 8/15/2024 Armistice Capital LLC2,336,000$6.17M0.1%+1.7%9.414% 8/9/2024 Renaissance Technologies LLC136,773$361K0.0%+57.1%0.551% Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2024 Dimensional Fund Advisors LP30,233$80K0.0%N/A0.122% 8/8/2024 Marco Investment Management LLC30,344$80K0.0%+22.3%0.122% 5/14/2024 CM Management LLC160,000$330K0.3%+14.3%0.645% 5/10/2024 Vanguard Group Inc.969,121$2.00M0.0%+39.4%3.906% 2/13/2024 Armistice Capital LLC2,189,000$3.94M0.1%+20.0%9.045% 11/15/2023 Armistice Capital LLC1,824,000$2.50M0.0%-1.0%7.538% 10/19/2023 Jmac Enterprises LLC58,041$80K0.0%-27.5%0.246% 8/15/2023 BVF Inc. IL4,326,710$5.93M0.2%+86.0%18.372% 8/11/2023 SVB Financial Group18,025$25K0.0%-33.1%0.080% 7/20/2023 Jmac Enterprises LLC80,041$110K0.0%+46.8%0.356% 2/9/2023 CM Management LLC234,800$535K0.6%-4.2%1.706% 11/14/2022 Cormorant Asset Management LP1,223,500$3.38M0.2%-6.3%8.894% 11/14/2022 Point72 Asset Management L.P.375,000$1.04M0.0%-12.5%2.726% 11/14/2022 Boothbay Fund Management LLC22,050$61K0.0%-36.3%0.160% 11/4/2022 CM Management LLC245,000$676K0.8%+8.9%1.781% 8/16/2022 Woodline Partners LP516,675$1.26M0.0%-23.2%3.755% 5/9/2022 CM Management LLC225,000$887K0.7%+95.7%1.636% 4/25/2022 Bailard Inc.27,600$109K0.0%N/A0.193% 2/14/2022 Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016% 2/11/2022 Ensign Peak Advisors Inc77,100$340K0.0%+966.7%0.539% 2/7/2022 Ameritas Advisory Services LLC24,219$107K0.0%N/A0.169% 2/2/2022 CM Management LLC115,000$507K0.4%+53.3%0.804% 11/16/2021 Two Sigma Advisers LP115,900$716K0.0%+48.0%0.810% 11/16/2021 Two Sigma Investments LP115,324$713K0.0%+100.5%0.806% 11/16/2021 BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530% 11/15/2021 Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464% 11/15/2021 Eversept Partners LP114,008$705K0.1%N/A0.797% 11/15/2021 Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051% 11/10/2021 Mercer Global Advisors Inc. ADV16,726$103K0.0%N/A0.117% 8/18/2021 Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446% 8/17/2021 Woodline Partners LP857,445$6.78M0.1%-3.8%5.993% 8/17/2021 Boothbay Fund Management LLC40,052$317K0.0%+39.6%0.280% 8/16/2021 Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319% 8/16/2021 Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948% Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself.8/16/2021 State Street Corp32,935$261K0.0%N/A0.230% 8/13/2021 Renaissance Technologies LLC21,107$167K0.0%-22.0%0.148% 8/13/2021 Northern Trust Corp32,116$254K0.0%+106.8%0.224% 8/13/2021 Geode Capital Management LLC124,614$985K0.0%+25.7%0.871% 8/13/2021 Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466% 5/19/2021 Logos Global Management LP224,071$2.40M0.2%N/A1.566% 5/18/2021 BVF Inc. IL1,113,435$11.91M0.4%N/A7.782% 5/18/2021 Millennium Management LLC14,588$156K0.0%N/A0.102% 5/18/2021 Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874% 5/18/2021 Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894% 5/18/2021 Citadel Advisors LLC25,062$268K0.0%N/A0.175% 5/17/2021 Woodline Partners LP891,055$9.53M0.2%N/A6.228% 5/17/2021 EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798% 5/17/2021 Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495% 5/17/2021 Ikarian Capital LLC250,000$2.68M0.1%N/A1.747% 5/13/2021 Renaissance Technologies LLC27,051$289K0.0%N/A0.189% 5/12/2021 Northern Trust Corp15,528$166K0.0%N/A0.109% 5/12/2021 Geode Capital Management LLC99,123$1.06M0.0%N/A0.693% 5/12/2021 CM Management LLC75,000$803K0.6%N/A0.524% 5/7/2021BlackRock Inc.12,282$131K0.0%N/A0.086% 4/21/2021 Ingalls & Snyder LLC51,149$547K0.0%N/A0.358% (Data available from 1/1/2016 forward) ELDN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELDN shares? During the previous two years, 13 institutional investors and hedge funds held shares of Eledon Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($6.17M), BVF Inc. IL ($5.93M), Zimmer Partners LP ($3.57M), Vanguard Group Inc. ($2.00M), Nantahala Capital Management LLC ($1.58M), Geode Capital Management LLC ($942K), and Renaissance Technologies LLC ($361K).Learn more on ELDN's institutional investors. What percentage of Eledon Pharmaceuticals stock is owned by institutional investors? 56.77% of Eledon Pharmaceuticals stock is owned by institutional investors. Learn more on ELDN's institutional investor holdings. Which institutional investors have been buying Eledon Pharmaceuticals stock? Of the 11 institutional investors that purchased Eledon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2M), Nantahala Capital Management LLC ($600K), Armistice Capital LLC ($404K), Vanguard Group Inc. ($273.70K), Renaissance Technologies LLC ($49.70K), Geode Capital Management LLC ($33.57K), and Dimensional Fund Advisors LP ($30.23K). How much institutional buying is happening at Eledon Pharmaceuticals? Institutional investors have bought a total of 3,453,747 shares in the last 24 months. This purchase volume represents approximately $6.06M in transactions. Which Eledon Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eledon Pharmaceuticals stock in the last 24 months: Zimmer Partners LP ($674.98K), Jmac Enterprises LLC ($22K), Armistice Capital LLC ($18.80K), CM Management LLC ($10.20K), and SVB Financial Group ($8.92K). How much institutional selling is happening at Eledon Pharmaceuticals? Institutional investors have sold a total of 734,897 shares in the last 24 months. This volume of shares sold represents approximately $1.77M in transactions. Related Companies BCYC Institutional Ownership AVDL Institutional Ownership COLL Institutional Ownership BCAX Institutional Ownership ZYME Institutional Ownership GYRE Institutional Ownership PSTX Institutional Ownership PAHC Institutional Ownership COGT Institutional Ownership NUVB Institutional Ownership This page (NASDAQ:ELDN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELDN Stock Alerts